Heron Therapeutics Inc (HRTX)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.07
0.00 (0.00%)
After-Hours: 19:24
Heron Therapeutics Profit Margin (Quarterly): -14.78% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -14.78% |
June 30, 2024 | -25.64% |
March 31, 2024 | -9.11% |
December 31, 2023 | -31.33% |
September 30, 2023 | -79.56% |
June 30, 2023 | -132.4% |
March 31, 2023 | -110.6% |
December 31, 2022 | -66.17% |
September 30, 2022 | -157.8% |
June 30, 2022 | -204.0% |
March 31, 2022 | -272.4% |
December 31, 2021 | -264.6% |
September 30, 2021 | -225.6% |
June 30, 2021 | -271.9% |
March 31, 2021 | -262.8% |
December 31, 2020 | -302.3% |
September 30, 2020 | -291.7% |
June 30, 2020 | -243.5% |
March 31, 2020 | -203.1% |
December 31, 2019 | -165.1% |
September 30, 2019 | -78.82% |
June 30, 2019 | -137.0% |
March 31, 2019 | -199.4% |
December 31, 2018 | -171.8% |
September 30, 2018 | -193.8% |
Date | Value |
---|---|
June 30, 2018 | -223.8% |
March 31, 2018 | -451.8% |
December 31, 2017 | -621.6% |
September 30, 2017 | -488.4% |
June 30, 2017 | -502.9% |
March 31, 2017 | -1.39K% |
December 31, 2016 | -3.75K% |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-302.3%
Minimum
Dec 2020
-9.11%
Maximum
Mar 2024
-166.7%
Average
-184.1%
Median
Profit Margin (Quarterly) Benchmarks
Journey Medical Corp | -16.34% |
NovaBay Pharmaceuticals Inc | -49.65% |
Palatin Technologies Inc | -- |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -12.61% |
Return on Invested Capital | -20.08% |
Gross Profit Margin (Quarterly) | 71.17% |
Operating Margin (Quarterly) | -13.59% |
Return on Net Operating Assets | -21.16% |